And so, another working week is about to draw to a close. Nothing like a respite, yes? This is, of course, our signal to daydream about weekend plans. Our agenda is rather modest and includes visiting the tallest of short people at an institution of higher learning. Alas, we must also rake leaves, but will make time for a treasured nap. And you? Perhaps this a chance to catch up with family or take a leisurely drive in the country? Or maybe you can curl up with an e-book. Whatever you do, have a great time and, of course, be safe. See you soon…

Actavis Hit By Cargo Thieves (Securing Pharma)

Insight Recalls Nasal Spray Over Bacteria Concerns (MedCity News)

FDA Says Shortage Of Leukemia Drug Is Resolved (Dow Jones)

Senate Kills Drug Importation Amendment (Drug Store News)

Merck Boosts Investment In Singapore (Bernama)

Consumer Group Urges FDA Not To Expand Xarelto Indication (Reuters)

Google Exec Says Pharma Must Do More To Leverage The Internet (Pharma Times)

Niaspan Sales Remain Flat After Study Results (New York Times)

Merck Says Hepatitis C Drug Works In HIV Study Patients (CNBC)

FDA Extends Review Of Tysabri JC Virus Labeling (Reuters)

SAC Says Cougar Investment Based On Public Info (Bloomberg News)

Merck Cuts 50 Jobs From An NJ Office (Star-Ledger of New Jersey)

Bayer Chooses Location For Office Consolidation (Montville Patch)

EDITOR’S NOTE: Please check this post for updates throughout the morning

leaves pic thx to iowaspiritwalker